x
Filter:
Filters applied
- JAH_Position_Papers
- EditorialRemove Editorial filter
- OtherRemove Other filter
- Middleman, Amy BRemove Middleman, Amy B filter
SAHM Position & Statement Papers
3 Results
- Position statement
Meningococcal Vaccine: A Position Statement of the Society for Adolescent Health and Medicine
Journal of Adolescent HealthVol. 50Issue 2p211–212Published in issue: February, 2012- Lisa S. Ipp
- Cora C. Breuner
- Amy B. Middleman
- SAHM Committee on Adolescent Vaccination
Cited in Scopus: 0Although rates of meningococcal disease have remained low in the United States since 2000, the severity of the disease, rapidity with which it strikes, and significant sequelae remain compelling reasons to employ all means possible to prevent it. Meningococcal disease has a bimodal peak distribution in the United States with its highest incidence rates in infants and adolescents aged 16 years and older. The 2005 recommendations from the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention were intended to protect youth entering adolescence including individuals 16–21 years of age, the ages at which meningococcal disease rates peak for children and young adults. - Position statement
Human Papillomavirus (HPV) Vaccine: A Position Statement of the Society for Adolescent Medicine
Journal of Adolescent HealthVol. 39Issue 4p620Published in issue: October, 2006- Lawrence S. Friedman
- Jessica Kahn
- Amy B. Middleman
- Susan L. Rosenthal
- Gregory D. Zimet
Cited in Scopus: 23Human papillomavirus (HPV) is the most common sexually transmitted infection (STI) worldwide, causing genital warts and nearly all cases of cervical cancer. On June 8, 2006, the Food and Drug Administration approved a three-dose HPV vaccine for use in females 9 to 26 years of age. The vaccine has been shown to be safe and effective in preventing infection with HPV types 16 and 18 (which cause approximately 70% of cervical cancers) as well as types 6 and 11 (which cause >90% of genital warts). As a prophylactic vaccine, it is most effective when administered before the onset of sexual activity. - Position paper
Adolescent immunizations: A position paper of the Society for Adolescent Medicine
Journal of Adolescent HealthVol. 38Issue 3p321–327Published in issue: March, 2006- Amy B. Middleman
- Susan L. Rosenthal
- Vaughn I. Rickert
- Lawrence Neinstein
- Daniel B. Fishbein
- Lawrence D'Angelo
Cited in Scopus: 80New vaccines are being targeted to help protect the adolescent population from disease. The Society for Adolescent Medicine strongly urges compliance with adolescent vaccination recommendations provided by the Advisory Committee on Immunization Practices. These vaccines will significantly impact the health and well-being of the adolescent population. To enhance vaccination compliance and access to prevention health care and promotion, the Society supports linking vaccination to the three distinct comprehensive preventive health care visits already recommended by multiple organizations during early, middle, and late adolescence.